Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Carmen P. McLean, PhD
JCP
Original Research
Methylene Blue Augmentation of Exposure Therapy for PTSD
August 23, 2017
Although exposure therapies are effective for PTSD, they require many sessions, and some patients still have residual symptoms. Methylene blue, an agent that enhances memory, has previously shown success...
Lori A. Zoellner
,
Michael Telch
,
Edna B. Foa
, et al
JCP
Original Research
Exposure and Response Prevention Helps Adults With Obsessive-Compulsive Disorder Who Do Not Respond to Pharmacological Augmentation Strategies
December 23, 2015
Carmen P. McLean
,
Laurie J. Zandberg
,
Page E. Van Meter
, et al
JCP
Original Research
Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder
April 22, 2015
Edna B. Foa
,
Helen Blair Simpson
,
David Rosenfield
, et al
JCP
Original Research
Treatment Response, Symptom Remission, and Wellness in Obsessive-Compulsive Disorder
July 15, 2013
Samantha G. Farris
,
Carmen P. McLean
,
Page E. Van Meter
, et al
